WSJ : Disney, Trian Blitz Shareholders for Votes in Last Stretch of Proxy Fight

Disney, Trian Blitz Shareholders for Votes in Last Stretch of Proxy Fight
Neuberger Berman supports Trian’s slate, citing the company’s succession woes, as others back CEO Bob Iger and his strategy

Chief Executive Bob Iger and activist investor Nelson Peltz have spent months of their proxy fight detailing their vision of Disney’s DIS 1.36%increase; green up pointing triangle future. For some investors, the deciding factor will be the company’s past.

Several investors casting votes ahead of the company’s April 3 meeting said they are grappling with whether Disney’s board is capable of choosing a strong successor to Iger. They have criticized the board for its role in selecting Bob Chapek in 2020, ousting him two years later and then extending Iger’s contract after he returned.

Neuberger Berman, which has long had a small stake in Disney, says it decided to support the nominees of Peltz’s hedge fund, Trian Partners, in large part because of the board’s past succession-planning issues. Trian is seeking board seats for Peltz and former Disney Chief Financial Officer Jay Rasulo.

“We don’t think it would create undue harm for shareholders to have another couple of independent eyes and ears,” said Joseph Amato, chief investment officer and president of Neuberger Berman, in an interview. The investment firm, which manages $463 billion in assets, owns roughly 0.1% of Disney shares, a stake valued at $254 million, and discloses voting intentions at certain companies it holds.

Disney said in a letter to shareholders this month that its board and succession-planning committee are conducting a “diligent and thorough succession planning process.” It said naming a new CEO with a strong team of senior leaders is a top priority.

Some institutional investors who plan to vote for Disney’s slate said that Iger has already demonstrated a commitment to correcting the company’s course, and that executive talent and strategy going forward are more important than the exact makeup of the board. While Peltz’s campaign might have helped accelerate change, these investors said they don’t think he needs to be part of Disney’s board.

Disney has won support from several big-name shareholders, including “Star Wars” creator George Lucas and Laurene Powell Jobs, the widow of Apple co-founder Steve Jobs. Former Disney CEO Michael Eisner—who stepped down as chairman after a shareholder revolt in 2004—as well as JPMorgan Chase CEO Jamie Dimon and the descendants of Walt Disney and his brother Roy have also publicly supported Disney.

The fight is far from over, and could result in a variety of outcomes. It is always possible the two sides could reach a last-minute settlement ahead of the meeting.

Casting votes
Many of the company’s largest institutional shareholders such as BlackRock and Vanguard have yet to cast their votes and often wait until closer to the deadline. Individual investors are expected to have outsize sway, given that they hold more than one-third of shares.

So far, a minority of shareholders have voted. As of Tuesday, just over 22% of shares had been cast, according to people familiar with the matter, the bulk of them held by individual and other smaller investors.

Among those who have already cast their votes, Peltz leads Disney director Maria Elena Lagomasino, while Rasulo, the other name on the Trian slate, has so far failed to gain much of a foothold with shareholders, these people said.

A spokesman for Disney said leaking an early vote count was “a highly inappropriate attempt to sway votes.”

Most shareholders are able to vote or alter a previous vote until the polls are officially closed, which happens the day of the annual meeting.

Courting shareholders
Disney and Trian continue to dart around the U.S. making their final cases for why shareholders should back their nominees in what has become a tight race.

Iger has personally visited major shareholders in recent weeks, while senior executives including finance chief Hugh Johnston and Alexia Quadrani, executive vice president of investor relations, have met with others. In some cases, Disney board members including Chairman Mark Parker and Lagomasino, who is known as “Mel” and is one of the board members whose seat Trian is contesting, have also attended shareholder meetings.

Disney has told investors in private meetings that it would be problematic and disruptive for the company and Iger if Peltz joins the board and that his presence in the boardroom would slow down decision making. It has also talked about the company’s streaming strategy and focus on revitalizing its studio.

Peltz and his team, which includes his son Matt, a partner at Trian, and another young partner, Ryan Bunch, have made dozens of shareholder visits, including trips to Canada and the U.K. Some large shareholders have received multiple visits.

Some major institutional investors are still undecided because they say both sides have made valid points.

While Iger is viewed as a strong CEO, some see value in having an outside voice to raise questions and challenge opinions in the boardroom. Several investors said Disney’s addition of former Morgan Stanley CEO James Gorman to its board was a good sign of its commitment to succession, given the smooth leadership transition he oversaw at his bank last year.

Some investors say they have considered the possibility that Iger might step down from the board should Peltz or Rasulo win a seat.

Iger would be “the first person to tell you that the business he is running today isn’t the same business he was running years ago,” said Michael Cuggino, president and a portfolio manager of the Permanent Portfolio Family of Funds, a small Disney shareholder. “If he decides to leave, maybe it’s a ‘so what.’”

Divided decisions
The two largest and most influential proxy-advisory firms were split in their recommendations to shareholders. Glass Lewis advised investors to vote in favor of Disney’s board nominees, while Institutional Shareholder Services recommended that shareholders vote to add Peltz to the board, but not Rasulo, and support all but one of Disney’s nominees.

A third and less well-known proxy adviser, Egan-Jones, weighed in on Trian’s side on Tuesday, enumerating concerns it had about Disney’s current management and board, including the lack of a long-term succession plan, weak financial performance and distracting forays into “the killing fields of the culture wars,” among others.

Disney delivered a blockbuster first-quarter earnings report in February, packed with announcements including a plan to take an equity stake in “Fortnite” maker Epic Games, an exclusive cut of pop star Taylor Swift’s Eras Tour concert movie that became available on Disney+ in March and a new streaming venture with rivals that could change how fans watch sports.

It said the company is on track to make its streaming business profitable by the end of September, a top priority for many shareholders, and in a rare departure from past years, provided guidance for profit expectations going forward, saying earnings per share are likely to increase 20% for the year.

Iger told colleagues before the earnings announcement that he expected the positive announcements to serve as a kind of knockout punch to Trian’s proxy campaign. People who have spoken to Iger in recent weeks have described him as confident and happy with the direction of the company.

He told one associate that he is confident Disney’s will prevail.

9to5 : Vision Pro engineers moved to folding iPhone project; delayed to 2027 – r

Vision Pro engineers moved to folding iPhone project; delayed to 2027 – report

A new supply-chain report reiterates earlier reports that some engineers previously working on Vision Pro have been moved to working a folding iPhone or iPad project.

It also claims that the planned launch of a foldable iPhone has been delayed from 2026 to 2027, but that suppliers have been told to stick to their existing schedules …

Recent reports on a folding iPhone
A January report said that display suppliers Samsung and LG have for some time been sending folding screen samples to Apple, and that the latest of these are in the 7-8 inch range.

It still remains unclear whether Apple is prioritising a folding iPhone or a folding iPad, and indeed the degree to which they might be described as one and the same. In our poll, the majority of you favored a device the size of an iPhone Pro which unfolds to a display the size of an iPad mini.

Another report said that Apple has at least two “active” prototypes which fold like a clamshell, but was concerned about a visible crease. A subsequent report made the unlikely claim that the project has been shelved for now.

Vision Pro engineers, and 2027 date
Digitimes carries the latest report, though cites another Korean publication.

According to Korea’s Alpha Biz, Apple higher-ups said after considering the preparation for various items, including foldable display supply, the launch of the foldable iPhone was adjusted from the fourth quarter of 2026 to the first quarter of 2027.

Despite the delay, major component manufacturers such as display suppliers are expected to proceed according to the original schedule […]

Recent reports noted that Apple has undergone an internal personnel adjustment. Staff who previously worked on the Vision Pro were allegedly sent to work on foldable devices instead.

9to5Mac’s Take
It’s clear that Apple has so far succeeded in keeping its work in this area pretty quiet, as all the folding iPhone reports to date contain more speculation than demonstrable fact – and this one is no exception.

It would be no surprise at all for some Vision Pro engineers to be moved from a product which has launched to another which is still in development. In particular, it would make perfect sense to reassign those adept at solving problems which arise during the design, prototyping, and pre-production phases. This much, then, is almost certainly true.

As for dates, these fall squarely into the speculative box. Apple will do what it always does, and launch any new product as and when it feels it has solved the problems raised by new product categories, and has something it believes is better than existing products. So far, there is no solid indication that any firm date has been set.

>>> US Research Calls

Research Calls
  • Upgrades:
    • Allstate (ALL) upgraded to Buy from Hold at HSBC Securities; tgt raised to $190
    • Estee Lauder (EL) upgraded to Buy from Neutral at BofA Securities; tgt $170
    • Lands' End (LE) upgraded to Buy from Hold at Craig Hallum; tgt raised to $15
    • Millicom International Cellular (TIGO) upgraded to Overweight from Neutral at JP Morgan
    • Omnicom (OMC) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $115
    • PNC (PNC) upgraded to Hold from Reduce at HSBC Securities; tgt raised to $155
    • Public Storage (PSA) upgraded to Strong Buy from Mkt Perform at Raymond James; tgt $330
    • Triumph Group (TGI) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $18
    • U.S. Bancorp (USB) upgraded to Buy from Hold at HSBC Securities; tgt raised to $53
    • Vornado Rlty Trust (VNO) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $26
  • Downgrades:
    • Albany Intl (AIN) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $95
    • Apple (AAPL) downgraded to Hold from Buy at DZ Bank; tgt $180
    • Bank of America (BAC) downgraded to Hold from Buy at HSBC Securities; tgt raised to $39
    • Extra Space Storage (EXR) downgraded to Outperform from Strong Buy at Raymond James; tgt $160
    • Galapagos NV (GLPG) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $31
    • Molina Healthcare (MOH) downgraded to Underperform from Neutral at BofA Securities; tgt $439
    • Palantir Technologies (PLTR) downgraded to Sell from Neutral at Monness Crespi & Hardt; tgt $20
    • Pebblebrook Hotel Trust (PEB) downgraded to Neutral from Buy at Compass Point; tgt $17
    • Vista Energy (VST) downgraded to Neutral from Buy at UBS; tgt raised to $47
    • Weibo (WB) downgraded to Neutral from Buy at Goldman
  • Others:
    • ADC Therapeutics (ADCT) initiated with a Buy at Guggenheim; tgt $11
    • Aquestive Therapeutics (AQST) initiated with an Outperform at Raymond James; tgt $7
    • Bentley Systems (BSY) initiated with an Outperform at William Blair
    • CyberArk (CYBR) initiated with a Buy at BTIG Research; tgt $317
    • Global Net Lease (GNL) initiated with a Hold at Truist; tgt $7
    • Grindr (GRND) initiated with a Buy at TD Cowen; tgt $12
    • Immunovant Sciences (IMVT) initiated with an Outperform at Oppenheimer; tgt $50
    • Jasper Therapeutics (JSPR) initiated with an Outperform at RBC Capital Mkts; tgt $70
    • Merus (MRUS) initiated with a Buy at Truist; tgt $69
    • Progress Software (PRGS) initiated with a Buy at DA Davidson; tgt $65
    • Scholar Rock (SRRK) initiated with a Strong Buy at Raymond James; tgt $30
    • SI-BONE (SIBN) initiated with an Overweight at Piper Sandler; tgt $25
    • Solid Biosciences (SLDB) initiated with an Outperform at William Blair; tgt $40
    • TransMedics Group (TMDX) initiated with an Overweight at Piper Sandler; tgt $95
    • TruBridge (TRBG) initiated with an Outperform at RBC Capital Mkts; tgt $13
    • Veru (VERU) initiated with an Outperform at Raymond James; tgt $3
    • Xeris Biopharma (XERS) initiated with an Outperform at Oppenheimer; tgt $5